Fitbit’s upcoming Sense smartwatch is its most superior well being tracker so far. And that declare simply grew stronger, because the firm acquired FDA clearance to activate its EKG electrocardiogram (EKG) coronary heart monitor app earlier than the watch even releases.
A smartwatch EKG screens your coronary heart rhythm and appears for proof of atrial fibrillation (AFib), which is the most typical kind of irregular heartbeat. Due to the implications of well being monitoring, corporations want FDA clearance earlier than they will provide the characteristic to customers.
“Serving to individuals perceive and handle their coronary heart well being has at all times been a precedence for Fitbit, and our new ECG app is designed for these customers who need to assess themselves within the second and assessment the studying later with their physician,” stated Eric Friedman, Fitbit co-founder and CTO. “Early detection of AFib is vital, and I’m extremely excited that we’re making these improvements accessible to individuals around the globe to assist them enhance their coronary heart well being, stop extra critical situations and probably save lives.”
AFib might be tough to detect and places individuals at an elevated danger of stroke. Usually, individuals don’t understand they have been in AFib till after a stroke. Early detection can result in higher well being outcomes, in any case.
The Fitbit Sense marks the third smartwatch with an app cleared for EKG use, following the Apple Watch and Samsung. The clearance comes simply in time for Fitbit to launch the brand new gadget with the characteristic turned on, one thing Samsung didn’t handle with the Galaxy Active2.